ABIVAX (EPA:ABVX) | WebDisclosure

BRIEF

published on 05/14/2025 at 18:05, 16 days 19 hours ago

ABIVAX: Number of shares and voting rights as of April 30, 2025

Voting Rights Actions Abivax AMF Regulations Financial Transparency
BRIEF

published on 05/14/2025 at 18:05, 16 days 19 hours ago

ABIVAX : Nombre d'actions et droits de vote au 30 avril 2025

Droits De Vote Actions Abivax Réglementation AMF Transparence Financière
PRESS RELEASE

published on 05/14/2025 at 18:00, 16 days 20 hours ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 30.04.25.
ABIVAX communique le nombre d'actions et de droits de vote au 30 avril 2025, conformément aux réglementations en vigueur

Droits De Vote Capital Social Actions Abivax Réglementaire
BRIEF

published on 04/29/2025 at 22:10, 1 month 1 day ago

Abivax Completes Enrollment for Phase 3 Ulcerative Colitis Trials

Abivax Obefazimod Ulcerative Colitis Phase 3 Trials Clinical Enrollment
BRIEF

published on 04/29/2025 at 22:10, 1 month 1 day ago

Abivax finalise le recrutement pour les essais de phase 3 sur la rectocolite hémorragique

Abivax Obefazimod Rectocolite Hémorragique Essais De Phase 3 Inscription Clinique
PRESS RELEASE

published on 04/29/2025 at 22:05, 1 month 1 day ago

Abivax annonce la fin du recrutement des patients dans le cadre de ses essais de phase 3 ABTECT dans le traitement de la rectocolite hémorragique (RCH) modérément à sévèrement active
Abivax annonce la fin du recrutement des patients pour les essais de phase 3 ABTECT dans le traitement de la rectocolite hémorragique. Premiers résultats attendus au T3 2025

Abivax Obefazimod Rectocolite Hémorragique Essais De Phase 3 RCH
PRESS RELEASE

published on 04/29/2025 at 22:05, 1 month 1 day ago

Abivax annonce la fin du recrutement des patients dans le cadre de ses essais de phase 3 ABTECT dans le traitement de la rectocolite hémorragique (RCH) modérément à sévèrement active
Abivax annonce la fin du recrutement des patients pour ses essais de phase 3 ABTECT dans le traitement de la rectocolite hémorragique (RCH). Premiers résultats attendus T3 2025

Abivax Rectocolite Hémorragique Phase 3 ABTECT RCH
PRESS RELEASE

published on 04/29/2025 at 22:05, 1 month 1 day ago

Abivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active Ulcerative Colitis
Abivax completes enrollment for Phase 3 ABTECT Trials in patients with active ulcerative colitis. Top-line results expected in Q3 2025, NDA submission planned for H2 2026

Abivax Ulcerative Colitis Phase 3 ABTECT Trials NDA Submission
BRIEF

published on 04/22/2025 at 22:10, 1 month 8 days ago

Abivax: Terms of the Annual General Meeting and outlook for 2025

Biotechnology Abivax Clinical Trials Investment General Meeting 2025
BRIEF

published on 04/22/2025 at 22:10, 1 month 8 days ago

Abivax : Modalités de l'Assemblée Générale Annuelle et perspectives 2025

Investissement Biotechnologie Abivax Essais Cliniques Assemblée Générale 2025

Published on 05/31/2025 at 06:16, 7 hours 45 minutes ago

Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE
Published on 05/31/2025 at 03:30, 10 hours 31 minutes ago

Avant Brands Inc. Announces Voting Results From 2025 Annual General Meeting of Shareholders
Published on 05/31/2025 at 01:45, 12 hours 16 minutes ago

GLG Life Tech Corporation Reports 2025 First Quarter Financial Results
Published on 05/30/2025 at 23:10, 14 hours 51 minutes ago

CORRECTION: Nextech3D.ai Migrates MAP Dynamics to AWS, Enabling Scalable AI Architecture and Accelerated Deployment
Published on 05/30/2025 at 23:00, 15 hours 1 minute ago

Battery X Metals Achieves Full Capacity Recovery on a Real-World Imbalanced Battery from the #2 Out-of-Warranty Electric Vehicle Model in the United States in Preliminary Trial

View all ACCESSWIRE

Published on 05/31/2025 at 09:15, 4 hours 46 minutes ago

Hong Kong-headquartered International Mediation Body Established
Published on 05/30/2025 at 21:22, 16 hours 38 minutes ago

CPI PROPERTY GROUP publishes financial results for the first quarter of 2025
Published on 05/30/2025 at 20:30, 17 hours 31 minutes ago

IUTE GROUP ISSUES EUR 140 MILLION NEW SENIOR SECURED EUR 2025/2030 BONDS – Strong demand from existing investors and new subscriptions
Published on 05/30/2025 at 18:05, 19 hours 56 minutes ago

Eurobattery Minerals will submit additional documentation for the EPA at the end of June
Published on 05/30/2025 at 18:04, 19 hours 57 minutes ago

Funding Circle Holdings plc: POS-Transaction in Own Shares

View all EQS

Published on 05/30/2025 at 22:00, 16 hours 1 minute ago

Information sur les comptes annuels
Published on 05/30/2025 at 22:00, 16 hours 1 minute ago

Information on the Annual Financial Statements
Published on 05/30/2025 at 18:14, 19 hours 46 minutes ago

Emova Group - Rapport annuel de Durabilité 23/24
Published on 05/28/2025 at 23:00, 2 days 15 hours ago

Standstill Commitments to hold shares of the company
Published on 05/28/2025 at 23:00, 2 days 15 hours ago

Engagements collectifs de conservation de titres de la société

View all LES ECHOS COMFI WIRE

News